FDA Drug and Device Approvals: July 1, 2004 Yael Waknine July 1, 2004
The U.S. Food and Drug Administration (FDA) has approved leeches as a device for skin grafts and reattachment surgery, an oral HIV-2 antibody test with results in 20 minutes, generic dimenhydrinate injection for motion sickness, and a new device for the treatment of heart failure. The European Commission has granted the CE mark of approval for cetuximab in the treatment of metastatic colorectal cancer in the European Union (EU).
Very interesting reading indeed! The leeches might be very interesting to work with in a case of DVT! And the Oral HIV tests would mean a lot in the third world countries.